Both in Pharmaceuticals
Agios Pharmaceuticals vs UroGen Pharma
Over the past year AGIO returned −15.2% and URGN returned +111.3%; their daily moves had a correlation of -0.02.
AGIO −15.2% URGN +111.3%Growth of $1, one year, split-adjusted
| Metric | AGIO | URGN |
|---|---|---|
| Price | $33.30 | $40.45 |
| Market cap | $1.99B | $1.98B |
| Today | −0.36% | −1.10% |
| 1 month | −0.1% | −7.3% |
| 6 months | +12.5% | +137.9% |
| Year to date | +22.3% | +72.7% |
| 1 year | −14.5% | +120.6% |
| Revenue growth (YoY) | +259.3% | +199.2% |
| Gross margin | 93.3% | 90.9% |
| Net margin | −225.1% | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | 20.2× | 10.5× |
| Net cash | $617.6M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.8% | 52.3% |
| Short % of float | 13.4% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).